FOCUS ON: BLADDER CANCER
 
How will bladder Ca care change with new drug approvals?
"It certainly looks like these new therapies will provide better results. From the research and literature, it looks like significant improvement," says one urologist.
Learn more
ADVERTISEMENT
 
Sequential gemcitabine/docetaxel promising for recurrent NMIBC
"In this era of BCG shortage, we may be forced to develop new standards and alternative strategies for bladder preservation," writes Badar M. Mian, MD.
Read his column
 
ADVERTISEMENT
More help for your NMIBC patients.
Learn about a product approved for use in hospital and office/clinic settings that makes tumors glow bright pink during Blue Light Cystoscopy. It detects more NMIBC than White Light Cystoscopy alone. See the impact you could make.
 
 
MORE FROM UROLOGY TIMES
 
Checkpoint inhibitor Tx response similar between pure, variant UC histologies
Bladder-sparing treatments linked with high rates of progression in NMIBC subset
 
JOB OPPORTUNITIES